MedPacto, Inc. (KOSDAQ:235980)

MedPacto Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	6,528	11,997	15,009	72,604	359.85	1,293
Short-Term Investments	28,964	28,701	40,469	-	96,594	120,280
Cash & Short-Term Investments	35,492	40,699	55,479	72,604	96,954	121,573
Cash Growth	-26.61%	-26.64%	-23.59%	-25.11%	-20.25%	168.36%
Accounts Receivable	1,283	1,641	-0	0	0	0
Other Receivables	174.99	195.08	382.62	844.27	1,799	393.13
Receivables	2,138	2,425	382.62	844.27	1,799	393.13
Inventory	340.49	646.15	-	-	-	-
Prepaid Expenses	117.04	50.81	50.37	99.2	351.64	381.67
Other Current Assets	897.84	1,146	878.26	1,607	1,226	3,738
Total Current Assets	38,985	44,967	56,790	75,154	100,331	126,085
Property, Plant & Equipment	2,009	2,412	2,789	3,647	5,203	2,563
Long-Term Investments	21.67	-	224.28	626.12	994.75	3,384
Other Intangible Assets	586.05	595.27	228.37	343.13	438.24	565.62
Long-Term Accounts Receivable	0	42.54	0	0	0	0
Other Long-Term Assets	665.64	646.66	753.59	704.17	719.86	747.06
Total Assets	42,268	48,663	60,785	80,474	107,687	133,346

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	44.84	73.35	-	-	-	-
Accrued Expenses	197.16	193.12	190.98	182.83	237.49	230.18
Short-Term Debt	-	-	-	-	60,264	-
Current Portion of Leases	610.58	599.1	460.78	740.54	689.06	190.17
Other Current Liabilities	837.8	502.94	723.61	641.5	5,432	557.4
Total Current Liabilities	1,690	1,369	1,375	1,565	66,623	977.75
Long-Term Debt	-	-	-	-	-	75,413
Long-Term Leases	873.86	1,126	1,480	1,687	2,423	-
Other Long-Term Liabilities	208.27	186.47	186.55	137.28	142.18	13,413
Total Liabilities	2,773	2,681	3,042	3,389	69,188	89,803

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	17,138	17,138	17,138	16,790	10,540	10,258
Additional Paid-In Capital	241,056	240,612	239,555	233,030	165,396	141,372
Retained Earnings	-219,059	-212,105	-199,294	-179,154	-143,829	-108,076
Comprehensive Income & Other	361.15	337.87	345.38	242.42	215.57	-11.16
Total Common Equity	39,496	45,982	57,743	70,909	32,323	43,543
Shareholders' Equity	39,496	45,982	57,743	77,085	38,499	43,543
Total Liabilities & Equity	42,268	48,663	60,785	80,474	107,687	133,346

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1,484	1,725	1,941	2,427	63,377	75,603
Net Cash (Debt)	34,008	38,973	53,538	70,177	33,577	45,970
Net Cash Growth	-26.71%	-27.20%	-23.71%	109.00%	-26.96%	2.47%
Net Cash Per Share	992.85	1137.07	1589.63	3307.46	1009.58	2245.36
Filing Date Shares Outstanding	34.34	34.28	34.28	33.58	21.08	20.52
Total Common Shares Outstanding	34.34	34.28	34.28	33.58	21.08	20.52
Working Capital	37,295	43,598	55,415	73,589	33,708	125,108
Book Value Per Share	1150.03	1341.55	1684.70	2111.59	1533.28	2122.33
Tangible Book Value	38,910	45,387	57,515	70,566	31,884	42,977
Tangible Book Value Per Share	1132.97	1324.19	1678.04	2101.37	1512.49	2094.77
Machinery	4,341	4,297	1,053	1,244	3,799	2,914

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 30, 2026

Data Sources Report a data error